Conference
Bleeding risk of glycoprotein (GP) IIB IIIA inhibitors or thienopyridines with fondaparinux vs enoxaparin in acute coronary syndromes: Insights from the oasis 5 trial
Authors
Jolly SS; Afzal R; Theroux P; Fung A; Chrolavicius S; Yusuf S; Mehta SR
Volume
23
Pagination
pp. 223C-223C
Publisher
PULSUS GROUP INC
Publication Date
October 1, 2007
Conference proceedings
CANADIAN JOURNAL OF CARDIOLOGY
ISSN
0828-282X